J
James S. Goodwin
Researcher at University of Texas Medical Branch
Publications - 567
Citations - 36690
James S. Goodwin is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 97, co-authored 556 publications receiving 34455 citations. Previous affiliations of James S. Goodwin include New York University & Johns Hopkins University.
Papers
More filters
Rejection of Highly Efficacious Therapies
James S. Goodwin,Jean M. Goodwin +1 more
TL;DR: Tomatoes belong to the nightshade (Solanaceae) family and can cause death if ingested in sufficient quantity as mentioned in this paper. But the fact that the French and Italians were eating tomatoes in increasing quantities without seeming harm did not encourage colonial Americans to try them.
Attitudes About Micronutrient Supplements in American Academic Medicine
TL;DR: In the 20th century, academic medi-cine has resisted the concept that supplementation with micronutrients might have health benefits as mentioned in this paper, and this resistance is evident in several ways: (1) by uncritical accep-tance of news of toxicity, such as the belief that vitamin C supplements cause kidney stones; (2) by the angry, scornful tone used indiscussions of micRONutrientsupplementation in the leadingtextbooks of medicine; and (3) byignoring evidence for possible effi-cacy
Journal ArticleDOI
Heart Disease as the Number One Cause of Death Among the Elderly
TL;DR: The patient was an 89-year-old man who lived on Elliot Street, had increasing trouble getting around, was going down-hill, and had some mildhypertension, so his heart stopped and he had been dead for several hours.
Journal ArticleDOI
Association of Pain on Hospital Discharge with the Risk of 30-Day Readmission in Patients with Total Hip and Knee Replacement.
Ickpyo Hong,Jordan Westra,James S. Goodwin,Amol Karmarkar,Yong Fang Kuo,Kenneth J. Ottenbacher +5 more
TL;DR: It is demonstrated that the pain scores on the day of discharge are associated with 30-day hospital readmission in patients who received total knee and hip arthroplasty.